An announcement from Proteomics International Laboratories Ltd. ( (AU:PIQ) ) is now available.
Proteomics International Laboratories Ltd announced its participation in the WA Life Sciences Broker Meets Biotech event, where Dr. Richard Lipscombe will present a suite of diagnostic tests ready for launch. This presentation underscores the company’s commitment to advancing its position in the biotech industry and highlights its ongoing efforts to innovate in the field of predictive diagnostics, potentially benefiting stakeholders by improving disease treatment options.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, based in Perth, Western Australia, is a medical technology company specializing in predictive diagnostics and bio-analytical services, focusing on proteomics—the large-scale study of proteins. The company’s mission is to enhance healthcare by developing innovative tools for better disease treatment.
YTD Price Performance: -37.50%
Average Trading Volume: 170,184
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$65.5M
For a thorough assessment of PIQ stock, go to TipRanks’ Stock Analysis page.